Haemonetics
298 hedge funds and large institutions have $5.74B invested in Haemonetics in 2019 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 101 increasing their positions, 104 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 104
9% less capital invested
Capital invested by funds: $6.28B → $5.74B (-$535M)
Holders
298
Holding in Top 10
2
Calls
$2.04M
Puts
$230K
Top Buyers
| 1 | +$40.3M | |
| 2 | +$38.5M | |
| 3 | +$37.6M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$26.4M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$20.1M |
Top Sellers
| 1 | -$117M | |
| 2 | -$65.9M | |
| 3 | -$24.1M | |
| 4 |
Renaissance Technologies
New York
|
-$21.5M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$16.9M |